Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological …
DN Danforth Jr - Breast cancer research, 2013 - Springer
Breast cancer is the most common malignancy in women in the United States but significant
disparities exist for African American women compared to Caucasian women. African …
disparities exist for African American women compared to Caucasian women. African …
Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes?
DJ Blackman, CM Masi - Journal of Clinical Oncology, 2006 - ascopubs.org
Breast cancer is the most common noncutaneous malignancy and the second most lethal
form of cancer among women in the United States. Mortality from breast cancer has declined …
form of cancer among women in the United States. Mortality from breast cancer has declined …
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple …
KR Bauer, M Brown, RD Cress, CA Parise… - cancer, 2007 - Wiley Online Library
BACKGROUND. Tumor markers are becoming increasingly important in breast cancer
research because of their impact on prognosis, treatment, and survival, and because of their …
research because of their impact on prognosis, treatment, and survival, and because of their …
Update on triple‐negative breast cancer disparities for the United States: A population‐based study from the United States Cancer Statistics database, 2010 through …
LC Scott, LR Mobley, TM Kuo, D Il'yasova - Cancer, 2019 - Wiley Online Library
Background Triple‐negative breast cancer (TNBC) has been associated with a more
aggressive histology, poorer prognosis, and nonresponsiveness to hormone therapy. It is …
aggressive histology, poorer prognosis, and nonresponsiveness to hormone therapy. It is …
Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US from 2010 to 2016
Importance Breast cancer incidence trends by age and race/ethnicity have been
documented; it is less clear whether incidence trends of breast cancer molecular subtypes …
documented; it is less clear whether incidence trends of breast cancer molecular subtypes …
[HTML][HTML] Comparison of clinicopathological features and prognosis in triple-negative and non-triple negative breast cancer
J Qiu, X Xue, C Hu, H Xu, D Kou, R Li, M Li - Journal of cancer, 2016 - ncbi.nlm.nih.gov
Purpose: Triple-negative breast cancer (TNBC) has attracted more attention both clinically
and experimentally because of its high-risk biological characteristics and lacking of effective …
and experimentally because of its high-risk biological characteristics and lacking of effective …
Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 …
Background: Breast cancer is the most commonly diagnosed cancer and the second leading
cause of cancer death among women in the United States and varies systematically by race …
cause of cancer death among women in the United States and varies systematically by race …
Socioeconomic and other demographic disparities predicting survival among head and neck cancer patients
Background The Institute of Medicine (IOM) report,“Unequal Treatment,” which defines
disparities as racially based, indicates that disparities in cancer diagnosis and treatment are …
disparities as racially based, indicates that disparities in cancer diagnosis and treatment are …
Residential racial segregation and disparities in breast cancer presentation, treatment, and survival
Objective: To understand the role of racial residential segregation on Black-White disparities
in breast cancer presentation, treatment, and outcomes. Summary of Background Data …
in breast cancer presentation, treatment, and outcomes. Summary of Background Data …
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor‐negative, invasive breast cancer: The …
M Brown, A Tsodikov, KR Bauer, CA Parise… - Cancer, 2008 - Wiley Online Library
BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone
receptor (PR), and human epidermal growth factor receptor 2 (HER2)(triple negative [TN]) …
receptor (PR), and human epidermal growth factor receptor 2 (HER2)(triple negative [TN]) …